Oruka Therapeutics (ORKA) Shares Outstanding (Diluted Average) (2010 - 2024)

Oruka Therapeutics has reported Shares Outstanding (Diluted Average) for 7 years, with the latest figure at $14.5 million in Q2 2024.

• For the quarter ending Q2 2024, Shares Outstanding (Diluted Average) rose 0.65% year-over-year to $14.5 million; the trailing twelve-month figure through Jun 2024 stood at $14.5 million (up 0.65% YoY), and the FY2023 full-year result was $14.4 million, changed 0.04% from the prior year.
• Shares Outstanding (Diluted Average) for Q2 2024 stood at $14.5 million, roughly flat from $14.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $14.5 million in Q2 2024, with the low at $13.9 million in Q4 2021.
• Average Shares Outstanding (Diluted Average) over 4 years is $14.4 million, with a median of $14.4 million recorded in 2021.
• Peak annual rise in Shares Outstanding (Diluted Average) reached 3.64% in 2022, while the deepest fall reached 0.0% in 2022.
• Tracing ORKA's Shares Outstanding (Diluted Average) over 4 years: stood at $13.9 million in 2021, then increased by 3.64% to $14.4 million in 2022, then advanced by 0.04% to $14.4 million in 2023, then increased by 0.61% to $14.5 million in 2024.
• The last three Shares Outstanding (Diluted Average) figures came in at $14.5 million (Q2 2024), $14.5 million (Q1 2024), and $14.4 million (Q4 2023), per Business Quant data.

Peer Comparison